• Products
  • Suppliers
  • Sourcing Requests
Post Sourcing Request Exhibition
  • Ofev Study Results Released of Fibrotic Progression in Patients with IPF americanpharmaceuticacreview
    November 13, 2017
    Boehringer Ingelheim announced results from a descriptive Phase IIIb lung imaging study providing evidence for the first time that Ofev (nintedanib) slowed the fibrotic process versus placebo in people with idiopathic pulmonary fibrosis (IPF).

Contact Us

PharmaSources@imsinoexpo.com

Tel: (+86) 400 610 1188

WhatsApp/Telegram/Wechat: +86 13621645194

About Us
About PharmaSources
Terms of Service
Privacy Policy
Intellectual Property
Media Partners
Buy
Search Products
Post Sourcing Requests
Search Suppliers
CAS Search
Sell
Member Application
Advertising
Post Products
EZSourcing
Events
CPHI China
PMEC China
Conferences
Search Events
Help
FAQ
Contact Us
Feedback
PharmaSources Customer Service